Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Cancer risk and survival after contralateral prophylactic mastectomy evaluated
October 6th, 2005
Cancer risk reduction and survival after contralateral prophylactic mastectomy were evaluated in a recent report published in theBritish Journal of Cancer. "The clinical outcome of contralateral prophylactic mastectomy (CPM) in women with a BRCA1 or BRCA2 mutation and a personal history of invasive breast cancer is unknown. "Researchers in The Netherlands "identified a cohort of 148 female BRCA1 or BRCA2 mutation carriers (115 and 33, respectively) who previously were treated for unilateral invasive breast cancer stages I-IIIa." T. C. Vansprundel and colleagues reported, "In all, 79 women underwent a CPM, while the...
Source: Women's Health Weekly (2005-10-06)
|
